Literature DB >> 23748231

Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.

E K Uzel1, S Karaçam, O Eliçin, O Uzel.   

Abstract

PURPOSE: To compare the effect of two different intensity-modulated radiation therapy (IMRT) planning techniques on parotid gland doses in patients with nasopharyngeal carcinoma (NPC). PATIENTS AND METHODS: Radiotherapy for 10 NPC patients referred to the University of Istanbul Cerrahpasa Medical School was planned with arc- and static seven-field IMRT. The simultaneous integrated boost (SIB) technique was used to deliver 70 Gy (2.12 Gy per fraction) to the primary tumor and involved nodes; 60 Gy (1.81 Gy per fraction) to the entire nasopharynx and 54 Gy (1.63 Gy per fraction) to elective lymph nodes in 33 fractions. Plans also aimed to keep the mean parotid dose below 26 Gy and limit the maximum doses to the spinal cord and brain stem to 45 and 54 Gy, respectively. Mean parotid gland doses for the two planning techniques were compared using a paired t-test. Target coverage and dose inhomogeneity were evaluated by calculating conformity- (CI) and homogeneity index (HI) values.
RESULTS: Target coverage and dose homogeneity were identical and good for both planning techniques: CI = 1.05 ± 0.08 and 1.05 ± 0.08; HI = 1.08 ± 0.02 and 1.07 ± 0.01 for arc- and static field IMRT, respectively. Mean doses to contralateral parotid glands were 25.73 ± 4.27 and 27.73 ± 3.5 Gy(p = 0.008) for arc- and static field IMRT plans, respectively, whereas mean ipsilateral parotid doses were 30.65 ± 6.25 and 32.55 ± 5.93 Gy (non-significant p-value), respectively. Mean monitor units (MU) per fraction for the 10 patients were considerably lower for arc- than for static field treatments-540.5 ± 130.39 versus 1288.4 ± 197.28 (p < 0.001).
CONCLUSION: Normal tissues--particularly the parotid glands--are better spared with the arc technique in patients with NPC. MU and treatment times are considerably reduced in arc IMRT plans.

Entities:  

Mesh:

Year:  2013        PMID: 23748231     DOI: 10.1007/s00066-013-0344-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  35 in total

Review 1.  Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.

Authors:  V Grégoire; E Coche; G Cosnard; M Hamoir; H Reychler
Journal:  Radiother Oncol       Date:  2000-08       Impact factor: 6.280

2.  Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.

Authors:  Szu-Huai Lu; Jason Chia-Hsien Cheng; Sung-Hsin Kuo; Jason Jeun-Shenn Lee; Liang-Hsin Chen; Jian-Kuen Wu; Yu-Hsuan Chen; Wan-Yu Chen; Shu-Yu Wen; Fok-Ching Chong; Chien-Jang Wu; Chun-Wei Wang
Journal:  Radiother Oncol       Date:  2012-01-09       Impact factor: 6.280

3.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

4.  Uncertainties in model-based outcome predictions for treatment planning.

Authors:  J O Deasy; K S Chao; J Markman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

5.  Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques.

Authors:  K S Chao; N Majhail; C J Huang; J R Simpson; C A Perez; B Haughey; G Spector
Journal:  Radiother Oncol       Date:  2001-12       Impact factor: 6.280

6.  RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.

Authors:  Patricia Doornaert; Wilko F A R Verbakel; Michael Bieker; Ben J Slotman; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

Review 7.  Intensity-modulated radiation therapy in head and neck cancers: an update.

Authors:  Nancy Lee; Dev R Puri; Angel I Blanco; K S Clifford Chao
Journal:  Head Neck       Date:  2007-04       Impact factor: 3.147

8.  RapidArc volumetric modulated therapy planning for prostate cancer patients.

Authors:  Flemming Kjaer-Kristoffersen; Lars Ohlhues; Joakim Medin; Stine Korreman
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

9.  Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques.

Authors:  Antonella Fogliata; Alessandro Clivio; Giorgia Nicolini; Eugenio Vanetti; Luca Cozzi
Journal:  Radiother Oncol       Date:  2008-08-28       Impact factor: 6.280

Review 10.  Intensity-modulated radiation therapy for head and neck carcinoma.

Authors:  Vincent Grégoire; Wilfried De Neve; Avraham Eisbruch; Nancy Lee; Danielle Van den Weyngaert; Dirk Van Gestel
Journal:  Oncologist       Date:  2007-05
View more
  10 in total

1.  New possibilities for volumetric-modulated arc therapy using the Agility™ 160-leaf multileaf collimator.

Authors:  Nadine Blümer; Christian Scherf; Janett Köhn; Eugen Kara; Britta Loutfi-Krauß; Detlef Imhoff; Claus Rödel; Ulla Ramm; Jörg Licher
Journal:  Strahlenther Onkol       Date:  2014-07-25       Impact factor: 3.621

2.  MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.

Authors:  Yi-Kan Cheng; Li-Zhi Liu; Ning Jiang; Dan Yue; Ling-Long Tang; Fan Zhang; Li Lin; Xu Liu; Lei Chen; Jun Ma
Journal:  Strahlenther Onkol       Date:  2014-04-25       Impact factor: 3.621

3.  SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.

Authors:  J Gao; T-L Qian; C-Z Tao; Y-H Zhang; Y Zhou; J Yang; J He; R Wang; P-J Zhou
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

4.  Radiation recall dermatitis after docetaxel chemotherapy. Treatment by antioxidant ointment.

Authors:  Viola Duncker-Rohr; Ulrich Freund; Felix Momm
Journal:  Strahlenther Onkol       Date:  2014-03-11       Impact factor: 3.621

5.  Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1.

Authors:  Hongxia Yang; Gang Zhang; Xiaolin Che; Shudong Yu
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

6.  Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.

Authors:  Esengul Kocak-Uzel; G Brandon Gunn; Rivka R Colen; Micheal E Kantor; Abdallah S R Mohamed; Sara Schoultz-Henley; Paniyotis Mavroidis; Steven J Frank; Adam S Garden; Beth M Beadle; William H Morrison; Jack Phan; David I Rosenthal; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2014-04-17       Impact factor: 6.280

7.  Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer.

Authors:  Stéphanie Smet; Maarten Lambrecht; Bianca Vanstraelen; Sandra Nuyts
Journal:  Strahlenther Onkol       Date:  2014-08-29       Impact factor: 3.621

8.  Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.

Authors:  Lei Zeng; Yun-Ming Tian; Xue-Ming Sun; Ying Huang; Chun-Yan Chen; Fei Han; Shuai Liu; Mei Lan; Ying Guan; Xiao-Wu Deng; Tai-Xiang Lu
Journal:  Strahlenther Onkol       Date:  2014-05-17       Impact factor: 3.621

9.  Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.

Authors:  Shufang Liao; Yuan Xie; Yi Feng; Yuanyuan Zhou; Yufei Pan; Jinfang Fan; Jinglin Mi; Xiaoli Qin; Dacheng Yao; Wei Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-01       Impact factor: 4.553

10.  Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.

Authors:  Tai-Lin Huang; Ming-Hsien Tsai; Hui-Ching Chuang; Chih-Yen Chien; Yu-Tsai Lin; Wen-Ling Tsai; Fu-Min Fang
Journal:  Radiat Oncol       Date:  2020-04-19       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.